Papers

Kečkéšová Z., Donaher J.L., De Cock J., Freinkman E., Lingrell S., Bachovchin D.A., Bierie B., Tischler V., Noske A., Reinhardt F., Thiru P., Golub T.R., Vance J.E., Weinberg R.A.:
LACTB is a tumor suppressor that modulates lipid metabolism and cell state.
Nature 543: 681-686, 2017.

Dongre A., Rashidian M., Reinhardt F., Bagnato A., Kečkéšová Z., Ploegh H.L., Weinberg R.A.:
The epithelial-to-mesenchymal transition contributes to immune suppression in breast carcinomas. Cancer Research 77: 3982-3989, 2017.

Bierie B., Pierce S.E., Kroeger C., Stover D.G., Pattabiraman D.R., Thiru P., Liu Donaher J., Reinhardt F., Chaffer C.L., Kečkéšová Z., Weinberg R.A.:
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. PNAS 114: E2337-2346, 2017.

De Cock J.M., Shibue T., Dongre A., Kečkéšová Z., Reinhardt F., Weinberg R.A.:
Inflammation triggers Zeb1-dependent escape from latency. Cancer Research 76: 6778-6784, 2016.

Guo W., Kečkéšová Z., Donaher J.L., Reinhardt F., Shibue T., Itzkovitz S., Bell G., von Oudenaarden A., Weinberg R.A.:
Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148: 1015-1028, 2012.

*Kečkéšová Z., *Roussos E.T., Haley J.D., Epstein D.M., Weinberg R.A., Condeelis J.S.:
AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment. Cancer Research 70: 7360-7364, 2010.

Kečkéšová Z., Ylinen L.M.J., Towers G.J., Gifford R.J., Katzourakis A.:
Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses. Virology 384: 7-11, 2009.

Ylinen L.M., Kečkéšová Z., Webb B.L., Gifford R.J., Smith T.P., Towers G.J.:
Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. Journal of Virology 80: 7332-7338, 2006.

Kečkéšová Z., Ylinen L.M., Towers G.J.:
Cyclophilin A renders human immunodeficiency virus type 1 sensitive to old world monkey but not human TRIM5α antiviral activity. Journal of Virology 80: 4683-4690, 2006.

Passerini L.D., Kečkéšová Z., Towers G.J.:
Retroviral restriction factors Fv1 and TRIM5α act independently and can compete for incoming virus before reverse transcription. Journal of Virology 80: 2100, 2006.

Ylinen L.M., Kečkéšová Z., Wilson S.J., Ranasinghe S., Towers G.J.:
Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5α alleles. Journal of Virology 79: 11580-11587, 2005.

Kečkéšová Z., Ylinen L.M.J., Towers G.J.:
The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities. PNAS 101: 10780-10785, 2004.